Back
Beta Bionics, Inc. 10K Form
Sell
14
BBNX
Beta Bionics, Inc.
Last Price:
$12.51
Seasonality Move:
-41.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBNX News And Ratings
See the #1 stock for the next 7 days that we like better than BBNX
BBNX Financial Statistics
Sales & Book Value
| Annual Sales: | $100.3M |
|---|---|
| Cash Flow: | $-10.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.48 |
| Price / Book: | 1.95 |
Profitability
| EPS (TTM): | -1.67940 |
|---|---|
| Net Income (TTM): | $-73.2M |
| Gross Margin: | $55.5M |
| Return on Equity: | -28.73% |
| Return on Assets: | -24.79% |
Beta Bionics, Inc. Earnings Forecast
Key Beta Bionics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for BBNX is 55.40%.
-
The Selling, General & Administrative Expenses for BBNX have been equal to 92.20% of Gross Profit Margin.
-
The Research & Development expenses have been 34.70% of Revenue.
-
The Net Earning history of BBNX is -73.02% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 1 years.
Beta Bionics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | BBNX |
| Website: | betabionics.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 8.66 |
| Quick Ratio: | 7.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBNX Technical Analysis vs Fundamental Analysis
Sell
14
Beta Bionics, Inc. (BBNX)
is a Sell
Is Beta Bionics, Inc. a Buy or a Sell?
-
Beta Bionics, Inc. stock is rated a SellThe current Beta Bionics, Inc. [BBNX] share price is $12.63. The Score for BBNX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.